ENDPOINTS

Altimmune to put its incretin into addiction trials; Tarsus aims to raise $125M

Plus, news about Heidelberg, Accropeutics, Allarity Therapeutics, Cadrenal and Inovio: Altimmune to test its incretin in addiction: Following the path set by Novo Nordisk last week, Altimmune said Thursday at its R ...

Mar 14, 2025 - 16:18
 0
Altimmune to put its incretin into addiction trials; Tarsus aims to raise $125M
Plus, news about Heidelberg, Accropeutics, Allarity Therapeutics, Cadrenal and Inovio: Altimmune to test its incretin in addiction: Following the path set by Novo Nordisk last week, Altimmune said Thursday at its R ...
Read More

Tags:

Previous Article

Daily briefing: Should the Stanford Prison Experiment be retracted more than 50 ...

Next Article

Why the best companies don’t just innovate – they reinvent how they manage

Related Posts

Otsuka makes pipeline changes; Oculis reveals $100M offering

Otsuka makes pipeline changes; Oculis reveals $100M off...

Feb 14, 2025  0

Repare to lay off 75% of staff; Castle Creek inks $75M royalty deal

Repare to lay off 75% of staff; Castle Creek inks $75M ...

Feb 25, 2025  0

NIH payment cuts are 'reasoned and rational,' government says

NIH payment cuts are 'reasoned and rational,' governmen...

Feb 18, 2025  0